Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community


August 2018 Formularies Updates: One Hundred and four (104) Medications Added to Medicare Plan Drug Lists

Category: Monthly Formulary Changes
Published on 2018-08-29 14:10:12


The August 2018 Medicare Part D plan formulary (drug lists) data includes the addition of 104 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 73 different drugs, many with multiple strengths.

New Generic Drugs Introduced: See our article https://Q1News.com/709.html for highlights of the new generics.

New Brand-Name Drugs Introduced
In addition, 19 new brand-name drugs, some with multiple strengths, were added to Medicare Part D plan formularies.  These drugs include, AIMOVIG®, CETRAXAL®, IMPOYZ®, INTRAROSA®, JYNARQUE®, MATULANE®, ORTHO TRI-CYCLEN®, ORTHO-CYCLEN®, ORTHO-NOVUM®, OSPHENA®, SEEBRI NEOHALER®, SOLOSEC®, SYMFI®, TAVALISSE®, TEXACORT®, TOUJEO MAX SOLOSTAR®, UTIBRON NEOHALER®, VYLIBRA®, and ZYPITAMAG®.

What is the NDC?
The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 104 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 3
New Drug 32
New Drug and Strength 25
New Manufacturer 5
New Manufacturer and Strength 12
New Packaging 3
New Strength 20
New Strength and Delivery Form
1
New Strength and Packaging
3
Total New NDCs 104

Reminder: (1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan. (2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

The following chart details the first 104 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
55513084102 AIMOVIG 140 MG DOSE-2 AUTO INJCT New Drug
60842002101 AUVI-Q 0.1 MG AUTO-INJECTOR New Strength
52817031910 BACLOFEN 5 MG TABLET New Manufacturer and Strength
68180087911 BEKYREE 28 DAY TABLET [VIORELE] New Drug
00642746410 BENZNIDAZOLE 100 MG TABLET New Drug and Strength
00642746312 BENZNIDAZOLE 12.5 MG TABLET New Drug and Strength
42858049340 BUPRENORPHINE 10 MCG/HR PATCH [Butrans] New Strength
42858083940 BUPRENORPHINE 20 MCG/HR PATCH [Butrans] New Strength
42858075040 BUPRENORPHINE 5 MCG/HR PATCH [Butrans] New Strength
70860010610 CASPOFUNGIN ACETATE 50 MG VIAL New Drug and Strength
70860010710 CASPOFUNGIN ACETATE 70 MG VIAL New Drug and Strength
66992045014 CETRAXAL 0.2% EAR SOLUTION DROPERETTE New Drug
42195055014 CIPROFLOXACIN 0.2% OTIC SOLN DROPERETTE [Cetraxal] New Drug
67457054620 CLOFARABINE 20 MG/20 ML VIAL [Clolar] New Drug
16714046901 CLONAZEPAM 0.5 MG TABLET [Klonopin] New Manufacturer
16714047001 CLONAZEPAM 1 MG TABLET [Klonopin] New Manufacturer
00378191405 CLONAZEPAM 2 MG TABLET [Klonopin] New Manufacturer
00093541601 CLOZAPINE ODT 12.5 MG TABLET RAPDIS [Fazaclo] New Strength
00115132019 COLESEVELAM 625 MG TABLET [WelChol] New Drug
43975030710 CYCLOPHOSPHAMIDE 25 MG CAPSULE New Drug and Strength
43975030810 CYCLOPHOSPHAMIDE 50 MG CAPSULE New Drug and Strength
67457051305 DACTINOMYCIN 0.5 MG VIAL [Cosmegen] New Drug
63323062461 DEXTROSE 5%-WATER IV SOLN New Manufacturer and Strength
65862031130 DIDANOSINE DR 200 MG CAPSULE DR [Videx EC] New Strength
50742046316 DOCETAXEL 160 MG/16 ML VIAL New Manufacturer and Strength
00006306100 EMEND 150 MG VIAL New Strength and Delivery Form
70700011984 ESTARYLLA 0.25-0.035 MG TABLET [VyLibra] New Drug
00169320415 FIASP 100 UNIT/ML FLEXTOUCH INSULN PEN New Delivery Form
75834014830 FLUOXETINE HCL 60 MG TABLET New Manufacturer and Strength
00115172501 GRISEOFULVIN ULTRA 250 MG Tablet [Gris-Peg] New Manufacturer and Strength
00409272001 HEPARIN SOD 1,000 UNIT/ML VIAL New Strength
00074081702 HUMIRA 10 MG/0.1 ML SYRINGEKIT New Strength and Packaging
00074061602 HUMIRA 20 MG/0.2 ML SYRINGEKIT New Packaging
00074055402 HUMIRA 40 MG/0.4 ML PEN IJ KIT New Packaging
00074024302 HUMIRA 40 MG/0.4 ML SYRINGEKIT New Packaging
00074006702 HUMIRA PEDIATR CROHN'S 80-40MG SYRINGEKIT New Strength and Packaging
00074254003 HUMIRA PED CROHNS 80 MG/0.8 ML SYRINGEKIT New Strength and Packaging
69482070060 IMPOYZ 0.025% CREAM (g) New Drug
64011060128 INTRAROSA 6.5 MG VAG INSERT New Drug
70700011787 INTROVALE 0.15-0.03 MG TABLET TBDSPK 3MO [Setlakin] New Drug
59148008707 JYNARQUE 45 MG-15 MG TABLET SEQ New Drug and Strength
59148008807 JYNARQUE 60 MG-30 MG TABLET SEQ New Drug and Strength
59148008907 JYNARQUE 90 MG-30 MG TABLET SEQ New Drug and Strength
60432003708 LACTULOSE 10 GM/15 ML SOLUTION [Constulose] New Drug
31722054401 LITHIUM CARBONATE 150 MG CAP New Manufacturer and Strength
70700011484 LORYNA 3 MG-0.02 MG TABLET [Yaz] New Drug
54482005401 MATULANE 50 MG CAPSULE New Drug
00548540025 MEDROXYPROGESTERONE 150 MG/ML VIAL [Depo-Provera] New Delivery Form
17478038020 METHADONE HCL 200 MG/20 ML VIAL [Dolophine] New Drug
13811071010 METHYLPHENIDATE ER 72 MG TABLET ER 24 [RELEXXII] New Manufacturer and Strength
51862026201 METHYLPHENIDATE LA 10 MG CAP CPBP 50-50 [Ritalin LA] New Strength
51862026401 METHYLPHENIDATE LA 30 MG CAP CPBP 50-50 [Ritalin LA] New Strength
65862077628 MILI 0.25-0.035 MG TABLET [VyLibra] New Drug
67457032325 MOXIFLOXACIN 400 MG/250 ML BAG PIGGYBACK [Avelox I.V.] New Drug
54766077090 NAFTIN 1% GEL New Strength
50742051430 NITRO-DUR 0.2 MG/HR PATCH New Strength
50742051530 NITRO-DUR 0.3 MG/HR PATCH New Strength
50742051630 NITRO-DUR 0.4 MG/HR PATCH New Strength
50742051730 NITRO-DUR 0.6 MG/HR PATCH New Strength
50742051830 NITRO-DUR 0.8 MG/HR PATCH New Strength
00378731553 NORETH-ESTRAD-FE 1-0.02(24)-75 Chewable Tablet [Minastrin] New Drug
00074339930 NORVIR 100 MG POWDER PACKET New Delivery Form
50458019106 ORTHO TRI-CYCLEN 28 TABLET New Drug
50458019706 ORTHO-CYCLEN 28 TABLET New Drug
50458017606 ORTHO-NOVUM 1-35-28 TABLET New Drug and Strength
50458017806 ORTHO-NOVUM 7-7-7-28 TABLET New Drug and Strength
59630058090 OSPHENA 60 MG TABLET New Drug
00703409401 PALONOSETRON 0.25 MG/5 ML VIAL [Aloxi] New Manufacturer and Strength
17478022312 PILOCARPINE 1% EYE DROPS [Pilocar] New Drug and Strength
17478022412 PILOCARPINE 2% EYE DROPS [Pilocar] New Drug and Strength
17478022612 PILOCARPINE 4% EYE DROPS [Pilocar] New Drug and Strength
00406118160 QUETIAPINE ER 150 MG Tablet ER 24H [Seroquel XR] New Drug and Strength
00406118260 QUETIAPINE ER 200 MG Tablet ER 24H [Seroquel XR] New Drug and Strength
33342013609 QUETIAPINE ER 300 MG Tablet ER 24H [Seroquel XR] New Drug and Strength
00406118060 QUETIAPINE ER 50 MG Tablet ER 24H [Seroquel XR] New Drug and Strength
00023614290 RAPAFLO 8 MG CAPSULE New Manufacturer and Strength
00093330428 RECLIPSEN 28 DAY TABLET [Solia] New Drug
63402081506 SEEBRI NEOHALER 15.6 MCG INHAL CAP W/DEV New Drug
63323062374 SODIUM CHLORIDE 0.9% IV SOLN New Manufacturer
27437005101 SOLOSEC 2 GM GRANULE PACKET GRANDR PKT New Drug
70700011584 SYEDA 28 TABLET [Zarah] New Drug
49502047593 SYMFI 600-300-300 MG TABLET New Drug
00597028073 SYNJARDY XR 10-1,000 MG TABLET BP 24H New Strength
00597030045 SYNJARDY XR 12.5-1,000 MG TABLET BP 24H New Strength
00597029578 SYNJARDY XR 25-1,000 MG TABLET BP 24H New Strength
00597029059 SYNJARDY XR 5-1,000 MG TABLET BP 24H New Strength
00078095166 TASIGNA 50 MG CAPSULE New Strength
71332000101 TAVALISSE 100 MG TABLET New Drug and Strength
71332000201 TAVALISSE 150 MG TABLET New Drug and Strength
00178045501 TEXACORT 2.5% SOLUTION New Drug
00781348192 TIGECYCLINE 50 MG VIAL [Tygacil] New Drug and Strength
00024587102 TOUJEO MAX SOLOSTAR 300UNIT/ML INSULN PEN New Drug
65862077728 TRI-MILI 28 TABLET [Trinessa] New Drug
50102023313 TRI-VYLIBRA 28 TABLET [Trinessa] New Drug
00713067653 TRIAMCINOLONE 0.1% LOTION [Kenalog] New Drug
63402068106 UTIBRON NEOHALER 27.5-15.6 MCG CAP W/DEV New Drug
50383079212 VALPROIC ACID 500 MG/10 ML Solution [Depakene] New Manufacturer and Strength
47335076081 VENLAFAXINE HCL ER 37.5 MG TAB ER 24 [Venlafaxine] New Manufacturer and Strength
47335075983 VENLAFAXINE HCL ER 75 MG TABLET 24 [Venlafaxine] New Manufacturer and Strength
50102023513 VYLIBRA 28 TABLET New Drug and Strength
00023611001 ZENPEP DR 10,000 UNIT CAPSULE New Manufacturer
25208020009 ZYPITAMAG 1 MG TABLET New Drug and Strength
25208020109 ZYPITAMAG 2 MG TABLET New Drug and Strength
25208020209 ZYPITAMAG 4 MG TABLET New Drug and Strength

Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Pets are Family Too!
Use your drug discount card to save on medications for the entire family ‐ including your pets.

  • No enrollment fee and no limits on usage
  • Everyone in your household can use the same card, including your pets
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.